Researchers Discover Clues About PML Infection
Main Category: Multiple SclerosisArticle Date: 11 Sep 2009 - 1:00 PDT
email to a friend 
printer friendly 
view / write opinions 
rate articleCurrent Article Ratings:
| Patient / Public: |  |
2.89 (9 votes) |
| Health Professional: |  |
1 (3 votes) |
| Article Opinions: | 0 posts |
Research published today in the New England Journal of Medicine has described how progressive multifocal leukoencephalopathy (PML) infection may occur in people taking Tysabri, a drug licensed for use in relapsing remitting multiple sclerosis (MS).
PML is a serious and often fatal infection of the brain that is estimated to occur in approximately one in 1,000 people taking Tysabri over the course of 18 months.
So far 13 cases of PML have been reported worldwide in people taking Tysabri and research is focused on developing ways of predicting and preventing PML.
Source
Multiple Sclerosis Society
View drug information on Tysabri.
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Multiple Sclerosis headlines email to a friend printer friendly version
weekly newsletter daily news alerts
personalize your news
rss feeds
back to top
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |
